In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novavax Inc.

www.novavax.com

Latest From Novavax Inc.

Coronavirus Update: FDA Fast-Tracks Blood Plasma Trials, Novavax Closes In On Vaccine Start

As US cases set to reach half a million, FDA gives green light to blood plasma trials to help meet urgent need for therapies.

Coronavirus COVID-19 Infectious Diseases

Novavax Succeeds In Phase III Flu Vaccine Trial Against Sanofi’s Fluzone

Phase III trial could lead to mid-2020 BLA filing to prevent seasonal influenza in adults 65 and older. Novavax also talked up the potential value of its adjuvant in COVID-19 vaccine development.

Clinical Trials Vaccines

Tech Transfer Roundup: Coronavirus Research Collaborations Respond To Pandemic

Recent collaborations involving Ridgeback, Themis, Junshi, Moleculin, Can-Fite, Pluristem and Beroni highlight the intense increase in research in how to treat or prevent COVID-19.

Coronavirus COVID-19 Deals

Comment: Biopharma ‘Geniuses’ Battle To Contain Trump’s Coronavirus Expectations

President Trump invites biopharma CEOs to another toe-curling White House meeting – but even complacency and misinformation won’t stop research efforts.

US States Commercial
See All

Company Information

  • Industry
  • Biotechnology
    • Liposomes
  • Pharmaceuticals
    • Drug Delivery
    • Specialty Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Novavax Inc.
  • Senior Management
  • Stanley C Erck, Pres. & CEO
    John J Trizzino, SVP, CBO & CFO
    Gregory M Glenn, MD, Pres., R&D
    Russell P Wilson, SVP, Bus. Dev.
    Louis F Fries, MD, CMO
  • Contact Info
  • Novavax Inc.
    Phone: (240) 268-2000
    20 Firstfield Rd.
    Gaithersburg, MD 20878
    USA
UsernamePublicRestriction

Register